Pb1862: bruin cll-313: a phase 3 open-label, randomized study of pirtobrutinib vs bendamustine+rituximab in untreated patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (trial in progress)
HemaSphere（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要